These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 25300673)

  • 1. Update on the current recommendations and outcomes in pregnant women with antiphospholipid syndrome.
    Chighizola CB; Gerosa M; Trespidi L; Di Giacomo A; Rossi F; Acaia B; Meroni PL
    Expert Rev Clin Immunol; 2014 Nov; 10(11):1505-17. PubMed ID: 25300673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Thrombotic Antiphospholipid Syndrome: The Rationale of Current Management-An Insight into Future Approaches.
    Chighizola CB; Ubiali T; Meroni PL
    J Immunol Res; 2015; 2015():951424. PubMed ID: 26075289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiphospholipid syndrome: An update on risk factors for pregnancy outcome.
    De Carolis S; Tabacco S; Rizzo F; Giannini A; Botta A; Salvi S; Garufi C; Benedetti Panici P; Lanzone A
    Autoimmun Rev; 2018 Oct; 17(10):956-966. PubMed ID: 30118899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiphospholipid syndrome.
    George D; Erkan D
    Prog Cardiovasc Dis; 2009; 52(2):115-25. PubMed ID: 19732604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Apheresis in antiphospholipid syndrome (APS)].
    De Silvestro G; Tison T; Marson P
    G Ital Nefrol; 2012; 29 Suppl 54():S78-83. PubMed ID: 22388836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy Outcome in Women with Obstetric and Thrombotic Antiphospholipid Syndrome-A Retrospective Analysis and a Review of Additional Treatment in Pregnancy.
    Mayer-Pickel K; Eberhard K; Lang U; Cervar-Zivkovic M
    Clin Rev Allergy Immunol; 2017 Aug; 53(1):54-67. PubMed ID: 27395067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of 139 pregnancies in antiphospholipid-positive women not fulfilling criteria for antiphospholipid syndrome: a retrospective study.
    Del Ross T; Ruffatti A; Visentin MS; Tonello M; Calligaro A; Favaro M; Hoxha A; Punzi L
    J Rheumatol; 2013 Apr; 40(4):425-9. PubMed ID: 23418380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 14th International Congress on Antiphospholipid Antibodies Task Force report on obstetric antiphospholipid syndrome.
    de Jesus GR; Agmon-Levin N; Andrade CA; Andreoli L; Chighizola CB; Porter TF; Salmon J; Silver RM; Tincani A; Branch DW
    Autoimmun Rev; 2014 Aug; 13(8):795-813. PubMed ID: 24650941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing antiphospholipid syndrome in pregnancy.
    Schreiber K; Hunt BJ
    Thromb Res; 2019 Sep; 181 Suppl 1():S41-S46. PubMed ID: 31477227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention & treatment of obstetrical complications in APS: Is hydroxychloroquine the Holy Grail we are looking for?
    Meroni PL
    J Autoimmun; 2016 Dec; 75():1-5. PubMed ID: 27496152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical manifestations of antiphospholipid syndrome (APS) with and without antiphospholipid antibodies (the so-called 'seronegative APS').
    Rodriguez-Garcia JL; Bertolaccini ML; Cuadrado MJ; Sanna G; Ateka-Barrutia O; Khamashta MA
    Ann Rheum Dis; 2012 Feb; 71(2):242-4. PubMed ID: 21953349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What have we learned about antiphospholipid syndrome from patients and antiphospholipid carrier cohorts?
    Pengo V; Banzato A; Bison E; Bracco A; Denas G; Ruffatti A
    Semin Thromb Hemost; 2012 Jun; 38(4):322-7. PubMed ID: 22399307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of women with recurrent pregnancy losses and antiphospholipid antibody syndrome.
    Kwak-Kim J; Agcaoili MS; Aleta L; Liao A; Ota K; Dambaeva S; Beaman K; Kim JW; Gilman-Sachs A
    Am J Reprod Immunol; 2013 Jun; 69(6):596-607. PubMed ID: 23521391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiphospholipid antibody syndrome and fetal outcome.
    Djelmis J; Radoncić E; Ivanisević M
    Acta Med Croatica; 2001; 55(3):123-30. PubMed ID: 11852731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of various entities of antiphospholipid antibodies positivity on adverse pregnancy outcome. An epidemiological perspective.
    Spinillo A; Bellingeri C; De Maggio I; Riceputi G; Pandolfi MP; Spada C; Alpini C; Montecucco C; Beneventi F
    J Reprod Immunol; 2021 Jun; 145():103304. PubMed ID: 33677238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The treatment of anti-phospholipid syndrome: A comprehensive clinical approach.
    Chighizola CB; Andreoli L; Gerosa M; Tincani A; Ruffatti A; Meroni PL
    J Autoimmun; 2018 Jun; 90():1-27. PubMed ID: 29449131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiphospholipid syndrome: characteristics and obstetrical management.
    Nishiguchi T; Kobayashi T
    Curr Drug Targets; 2005 Aug; 6(5):593-605. PubMed ID: 16026280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphospholipid syndrome and pregnancy.
    Satta R; Biondi G
    G Ital Dermatol Venereol; 2019 Jun; 154(3):277-285. PubMed ID: 30375212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature.
    Andreoli L; Chighizola CB; Banzato A; Pons-Estel GJ; Ramire de Jesus G; Erkan D
    Arthritis Care Res (Hoboken); 2013 Nov; 65(11):1869-73. PubMed ID: 23861221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apheresis and intravenous immunoglobulins used in addition to conventional therapy to treat high-risk pregnant antiphospholipid antibody syndrome patients. A prospective study.
    Ruffatti A; Favaro M; Hoxha A; Zambon A; Marson P; Del Ross T; Calligaro A; Tonello M; Nardelli GB
    J Reprod Immunol; 2016 Jun; 115():14-9. PubMed ID: 27088752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.